AI Article Synopsis
- Vaping has become increasingly popular among young adults, leading to a concerning increase in vaping-related lung injuries known as EVALI.
- The exact chemicals causing these lung injuries are still under investigation, but tetrahydrocannabinol ( THC ) and vitamin E acetate are commonly linked to the majority of cases.
- The paper discusses clinical and imaging findings from three recent EVALI cases treated in an emergency department, highlighting the varied pulmonary diseases associated with this condition.
Article Abstract
Electronic-cigarette use (vaping), has gained popularity among the young adult population, causing an alarming rise in electronic-cigarette, or vaping, product use-associated lung injury (EVALI). The specific chemical agent(s) responsible for lung injuries remains to be further investigated, but tetrahydrocannabinol, the active ingredient in marijuana, and vitamin E acetate are involved in most cases. A variety of pulmonary diseases causing different imaging findings have been described with EVALI. The clinical and imaging findings of three cases recently seen in our emergency department are reviewed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.hrtlng.2020.01.005 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!